ClinicalTrials.gg
Drug

Endostar protein clinical trials

Also written Endostar.

studies test it
92
open now
16
in phase 3
10
first study started
1999

How each study uses endostar protein is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the endostar protein studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

recombinant human endostatin
20
Recombinant Human Endostatin Injection
8
rh-Endostatin
4
ENDO
3
Recombinant human endostatin (Endostar)
3

Brand

Endostar
55

Studies by the year they started

92 studies that test it; most in 2020 (8)

Studies that test endostar protein, by start year
YearStudies
19991
20001
20031
20073
20086
20096
20102
20115
20123
20135
20144
20156
20167
20176
20184
20195
20208
20213
20224
20231
20246
20251
20264

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
67
Phase 3
10
Phase 4
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 81

Zhejiang Cancer Hospital (9) · Fudan University (7) · Jiangsu Simcere Pharmaceutical Co., Ltd. (6) · Simcere Pharmaceutical Co., Ltd (6) · First Affiliated Hospital of Guangxi Medical University (4) · Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd (3) · Shanghai Jiao Tong University School of Medicine (2) · The First People's Hospital of Lianyungang (2)

Often tested with

Tested in the same studies.

Envafolimab (9) · Docetaxel (6) · Cisplatin (3) · Carboplatin (3) · Pemetrexed (3) · Toripalimab (3) · Gemcitabine (3) · Nedaplatin (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test endostar protein.

Studies

Open first, then newest update. How each study uses endostar protein is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 92

See all 92 studies that test endostar protein →

Given beside what is tested · 6 — endostar protein is usual care or a partner of the new treatment

Codes

What other systems call endostar protein · ClinicalTrials.gg INT005158

  • MeSH (NLM) C522911endostar proteinConfirmed ClinicalTrials.gov, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.